Abstract:The conversion of native soluble proteins into insoluble amyloid fibrils that are rich in cross β-sheet structure is associated with a variety of neurodegenerative diseases. It has recently become apparent that smaller oligomers formed during the early stages of amyloid fibril formation may be primarily responsible for the toxicity in amyloid diseases. Traditional ensemble techniques have limitations in characterization of oligomers due to the metastable and heterogeneous nature of these prefibrillar species. Single molecule fluorescence spectroscopy allows the conformational dynamics of individual biomolecules to be investigated, revealing properties that may be averaged in the ensemble experiment. It is therefore extremely powerful for identification and characterization of the low-populated, heterogeneous and transient species formed during fibril assembly. Combining single molecule fluorescence with kinetic modeling can provide quantitative information regarding the microscopic steps in amyloid formation. Here we have applied single molecule fluorescence resonance energy transfer to investigate in detail the intermolecular assembly and aggregation process of the yeast prion protein Ure2. Oligomerization during the initial lag phase was observed, and two types of Ure2 oligomers with different assembly modes were identified. Furthermore, using theoretical analysis combined with single molecule and ensemble kinetic data, we describe the formation and depletion pathway of oligomers, and propose a multi-step mechanism for Ure2 fibril formation, in which initial oligomerization is followed by conformational conversion to β-sheet containing oligomers that are then able to grow to form mature amyloid fibrils. We also show directly that secondary nuclei do not form, and that fragmentation is therefore responsible for the autocatalytic behavior of Ure2, in contrast to the mechanism of the amyloid formation of Aβ peptide. These results shed light on the potential origin of differences in cytotoxicity between functional and disease-related amyloids.

Tuning protein assembly pathways through superfast amyloid-like aggregation

Tuning Self-Assembled Morphology of the Aβ(16-22) Peptide by Substitution of Phenylalanine Residues.

Energy Landscapes of the Monomer and Dimer of the Alzheimer’s Peptide Aβ(1–28)

Modeling and Designing Particle-Regulated Amyloid-like Assembly of Synthetic Polypeptides in Aqueous Solution

Systematic Analysis of Nucleation-Dependent Polymerization Reveals New Insights into the Mechanism of Amyloid Self-Assembly

Role of Monomer Arrangement in the Amyloid Self-Assembly.

Revealing the Mechanism of Amyloid Fibril Formation by Combined Single Molecule FRET and Kinetic Modeling

Computational studies of protein aggregation mediated by amyloid: Fibril elongation and secondary nucleation

Self-Assembly Pathways of Β-Sheet-rich Amyloid-β(1-40) Dimers: Markov State Model Analysis on Millisecond Hybrid-Resolution Simulations.

Exploring the Early Steps of Aggregation of Amyloid-Forming Peptide Kffe

Self-assembly of amyloid-forming peptides by molecular dynamics simulations.

Non-fibril Amyloid Aggregation at the Air/Water Interface: Self-adaptive Pathway Resulting in a 2D Janus Nanofilm

Self-Assembly of Full-Size Amyloid Beta 40 Proteins in Dimers

The Molecular Lifecycle of Amyloid – Mechanism of Assembly, Mesoscopic Organisation, Polymorphism, Suprastructures, and Biological Consequences

Amyloid-Like Assembly to Form Film at Interfaces: Structural Transformation and Application.

Self-Assembling ABETA(30-36) Peptides: A Combined All-Atom and Coarse-Grained Simulation Study

Designed 2D and 3D Protein Nanocage Networks Driven by Hydrophobic Interactions Contributed by Amyloidogenic Motifs.

Disulfide-Driven Charge and Hydrophobicity Rearrangement of Remodeled Membrane Proteins toward Amyloid-Type Aggregation

Long-range Regulation of Partially Folded Amyloidogenic Peptides

Non-native beta-sheet formation: insights into protein amyloidosis

Maturation-dependent changes in the size, structure and seeding capacity of Aβ42 amyloid fibrils